Literature DB >> 3596154

Characterization of serum cholinesterase in familial hyper-cholinesterasemia associated with an isozyme variant band.

K Yamamoto, F Morito, Y Setoguchi, S Fujii, T Kariya, T Sakai.   

Abstract

An investigation of the properties and kinetics of serum cholinesterase (chE) was conducted in familial cases of serum hyper-chE activity. An inhibition study with specific pseudo-chE inhibitor (ethopropazine), or with anti-human pseudo-chE sera, has produced evidence that this genetically variant chE is pseudo-chE. The Km or relative activity of the variant chE against enzyme protein turns out to be the same as that of the normal serum chE. However, the variant serum chE shows more basic pK in addition to the main pK of the normal pseudo-chE on isoelectrofocusing analysis. The serum chE isozyme analysis has revealed two different extrabands in the variant: one demonstrated as a sharp line between bands 3 and 4, which we described previously, and the other as slow migrating broad band in the cathodic region close to the origin. Both prove to be pseudo-chE. Although there have been some similar descriptions about the latter type of extraband, no reports are found about the former type. It is noteworthy that the use of heparin as an anti-coagulant caused the total disappearance of the first type of extraband. It should be remembered that only heparinized plasma was used in the earlier studies. Since the detection of the former type of band seems to be specific and is simple, our findings would probably help clinicians diagnose a familial case of hyper-chE.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3596154     DOI: 10.1007/bf02774216

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  17 in total

1.  Serum-cholinesterase levels in diabetes mellitus.

Authors:  R H THOMPSON; J R TROUNCE
Journal:  Lancet       Date:  1956-05-12       Impact factor: 79.321

2.  A relationship between body fat and plasma pseudo-cholinesterase.

Authors:  W T BERRY; P J COWIN; D R DAVIES
Journal:  Br J Nutr       Date:  1954       Impact factor: 3.718

3.  Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients.

Authors:  M I Chu; P Fontaine; K M Kutty; D Murphy; R Redheendran
Journal:  Clin Chim Acta       Date:  1978-04-03       Impact factor: 3.786

4.  Human plasma cholinesterase isoenzymes.

Authors:  P Juul
Journal:  Clin Chim Acta       Date:  1968-02       Impact factor: 3.786

5.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

6.  A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity.

Authors:  A Yoshida; A G Motulsky
Journal:  Am J Hum Genet       Date:  1969-09       Impact factor: 11.025

7.  [Serum cholinesterase activity in non-alcoholic fatty liver. Effect of obesity on the activity and role of its measurement in the differential diagnosis in chronic hepatitis].

Authors:  F Nomura; K Ohnishi; H Koen; T Ohtsuki; K Kohno; M Saitoh; T Nakayama; H Hatano; A Mishima; Y Hiyama
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1984-07

8.  An improved detection system applied to the study of serum lipoproteins after single-step density gradient ultracentrifugation.

Authors:  J Nilsson; V Mannickarottu; C Edelstein; A M Scanu
Journal:  Anal Biochem       Date:  1981-01-15       Impact factor: 3.365

9.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

10.  Increased plasma cholinesterase activity and succinylcholine resistance: a genetic variant.

Authors:  H W Neitlich
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

View more
  1 in total

1.  The C5 Variant of the Butyrylcholinesterase Tetramer Includes a Noncovalently Bound 60 kDa Lamellipodin Fragment.

Authors:  Lawrence M Schopfer; Hervé Delacour; Patrick Masson; Jacqueline Leroy; Eric Krejci; Oksana Lockridge
Journal:  Molecules       Date:  2017-06-29       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.